Pharmacare in Canada: one step forward, two steps back

If Canada did like every other OECD country, except the U.S., universal pharmacare would provide better access to prescription drugs for Canadians, says associate professor Marc-André Gagnon of Carleton University.

National universal pharmacare is clearly not a priority anymore for the federal government, writes Marc-André Gagnon, associate professor with the School of Public Policy and Administration at Carleton University.Photograph courtesy of Pixabay

Opinion

BY Marc-André Gagnon

February 7, 2022

Canadians pay 42 per cent more per capita for prescription drugs than the OECD average. A whopping nine per cent...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy